Glioblastoma (GBM) has the typical radiological appearance (TRA) of a centrally necrotic, peripherally enhancing tumor with surrounding edema. The objective of this study was to determine whether the developing GBM displays a spectrum of imaging changes detectable on routine clinical imaging prior to TRA GBM. Patients with pre-operative imaging diagnosed with GBM (1 January 2014–31 March 2022) were identified from a neuroscience center. The imaging was reviewed by an experienced neuroradiologist. Imaging patterns preceding TRA GBM were analyzed. A total of 76 out of 555 (14%) patients had imaging preceding TRA GBM, 57 had solitary lesions, and 19 had multiple lesions (total = 84 lesions). Here, 83% of the lesions had cortical or cortical/subcortical locations. The earliest imaging features for 84 lesions were T2 hyperintensity/CT low density (n = 18), CT hyperdensity (n = 51), and T2 iso-intensity (n = 15). Lesions initially showing T2 hyperintensity/CT low density later showed T2 iso-intensity. When CT and MRI were available, all CT hyperdense lesions showed T2 iso-intensity, reduced diffusivity, and the following enhancement patterns: nodular 35%, solid 29%, none 26%, and patchy peripheral 10%. The mean time to develop TRA GBM from T2 hyperintensity was 140 days and from CT hyperdensity was 69 days. This research suggests that the developing GBM shows a spectrum of imaging features, progressing through T2 hyperintensity to CT hyperdensity, T2 iso-intensity, reduced diffusivity, and variable enhancement to TRA GBM. Red flags for non-TRA GBM lesions are cortical/subcortical CT hyperdense/T2 iso-intense/low ADC. Future research correlating this imaging spectrum with pathophysiology may provide insight into GBM growth patterns.
Despite the welcome introduction of the NHS Lung Cancer Screening Programme, most diagnoses of lung cancer will continue to be made via symptomatic and emergency presentations. Multiple patient-related factors act as a barrier to symptomatic presentation and eventual diagnosis including perceptions of personal risk and a view that the often non-specific symptoms may be unworthy of medical attention in an ever-busy NHS. Self-request chest x-ray services rolled out in Leeds and Greater Manchester aim to reduce these barriers to diagnosis in order to achieve earlier diagnosis of lung cancer and improve outcomes. The services have been accessed over 14 000 times. Lung cancer is a leading cause of health inequality, and these services effectively target populations with high levels of deprivation who are at the greatest risk of lung cancer and yet face the greatest barriers to diagnosis. Self-request services empower patients to take ownership of their health. Supported by organizations representing those affected by lung cancer, the initiative is a step towards restoring access to healthcare. This commentary discusses the rationale for the self-request chest x-ray service and describes the service model, addressing areas of potential concern and controversy.